A randomized, double-blinded, placebo-controlled, dose-ranging study measuring the effect of an adenosine agonist on infarct size reduction in patients undergoing primary percutaneous transluminal coronary angioplasty: the ADMIRE (AmP579 Delivery fo (Q44507085)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized, double-blinded, placebo-controlled, dose-ranging study measuring the effect of an adenosine agonist on infarct size reduction in patients undergoing primary percutaneous transluminal coronary angioplasty: the ADMIRE (AmP579 Delivery fo |
scientific article |
Statements
1 reference
A randomized, double-blinded, placebo-controlled, dose-ranging study measuring the effect of an adenosine agonist on infarct size reduction in patients undergoing primary percutaneous transluminal coronary angioplasty: the ADMIRE (AmP579 Delivery fo (English)
1 reference
Stephen L Kopecky
1 reference
Ronnier J Aviles
1 reference
Malcolm R Bell
1 reference
Joseph K Lobl
1 reference
Diane Tipping
1 reference
Gregg Frommell
1 reference
Karen Ramsey
1 reference
Anne E Holland
1 reference
Mark Midei
1 reference
Abnash Jain
1 reference
Mirle Kellett
1 reference
Raymond J Gibbons
1 reference
AmP579 Delivery for Myocardial Infarction REduction study
1 reference
1 July 2003
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference